Patents by Inventor Laura Maguire

Laura Maguire has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11894147
    Abstract: A method for predicting an unfavorable outcome for a patient admitted to a hospital, e.g., with a COVID-19 infection is described. Attributes from an electronic health record for the patient are obtained including at least findings obtained at admission, basic patient characteristics, and laboratory data. The attributes are supplied to a classifier implemented in a programmed computer which is trained to predict a risk of the unfavorable outcome. The classifier is arranged as a hierarchical combination of (a) an initial binary classifier stratifying the patient into either a high risk group or a low risk group, and (b) child classifiers further classifying the patient in a lowest risk group or a highest risk group depending how the initial binary classifier stratified the patient as either a member of the high risk or low risk group.
    Type: Grant
    Filed: September 2, 2022
    Date of Patent: February 6, 2024
    Assignee: BIODESIX, INC.
    Inventors: Thomas Campbell, Robert W. Georgantas, III, Heinrich Röder, Joanna Röder, Laura Maguire
  • Publication number: 20230005621
    Abstract: A method for predicting an unfavorable outcome for a patient admitted to a hospital, e.g., with a COVID-19 infection is described. Attributes from an electronic health record for the patient are obtained including at least findings obtained at admission, basic patient characteristics, and laboratory data. The attributes are supplied to a classifier implemented in a programmed computer which is trained to predict a risk of the unfavorable outcome. The classifier is arranged as a hierarchical combination of (a) an initial binary classifier stratifying the patient into either a high risk group or a low risk group, and (b) child classifiers further classifying the patient in a lowest risk group or a highest risk group depending how the initial binary classifier stratified the patient as either a member of the high risk or low risk group.
    Type: Application
    Filed: September 2, 2022
    Publication date: January 5, 2023
    Applicant: BIODESIX, INC.
    Inventors: Thomas CAMPBELL, Robert W. GEORGANTAS, III, Heinrich RÖDER, Joanna RÖDER, Laura MAGUIRE
  • Publication number: 20220341939
    Abstract: A method for predicting whether an early stage (IA, IB) non-small-cell lung cancer (NSCLC) patient is at a high risk of recurrence of the cancer following surgery involves subjecting a blood-based sample from the patient (obtained prior to, at, or after the surgery) to mass spectrometry and classification with a computer implementing a classifier. If the patients blood sample is classified as “high risk”, highest risk“or the equivalent, the patient can be guided to more aggressive treatment post-surgery. The classifier, or combination of classifiers, can be arranged in a hierarchical manner to make intermediate classifications, such as intermediate/high or intermediate/low, as well as low risk” or “lowest risk” classifications. Such additional classifications may guide clinical decisions as well.
    Type: Application
    Filed: January 29, 2020
    Publication date: October 27, 2022
    Applicant: BIODESIX, INC.
    Inventors: Heinrich RODER, Joanna RÖDER, Lelia NET, Laura MAGUIRE
  • Patent number: 11476003
    Abstract: A method for predicting an unfavorable outcome for a patient admitted to a hospital, e.g., with a COVID-19 infection is described. Attributes from an electronic health record for the patient are obtained including at least findings obtained at admission, basic patient characteristics, and laboratory data. The attributes are supplied to a classifier implemented in a programmed computer which is trained to predict a risk of the unfavorable outcome. The classifier is arranged as a hierarchical combination of (a) an initial binary classifier stratifying the patient into either a high risk group or a low risk group, and (b) child classifiers further classifying the patient in a lowest risk group or a highest risk group depending how the initial binary classifier stratified the patient as either a member of the high risk or low risk group.
    Type: Grant
    Filed: June 10, 2021
    Date of Patent: October 18, 2022
    Assignee: BIODESIX, INC.
    Inventors: Thomas Campbell, Robert W. Georgantas, III, Heinrich Röder, Joanna Röder, Laura Maguire
  • Publication number: 20220188701
    Abstract: Shapley values (SVs) have become an important tool to further the goal of explainability of machine learning (ML) models. However, the computational load of exact SV calculations increases exponentially with the number of attributes. Hence, the calculation of SVs for models incorporating large numbers of interpretable attributes is problematic. Molecular diagnostic tests typically seek to leverage information from hundreds or thousands of attributes, often using training sets with fewer instances. Methods are described for evaluate SVs using Monte Carlo sampling or exact calculation in polynomial time (i.e., reasonably quickly and efficiently) using the architecture of a ML model designed for robust molecular test generation, and without requiring classifier retraining.
    Type: Application
    Filed: June 28, 2021
    Publication date: June 16, 2022
    Applicant: BIODESIX, INC.
    Inventors: Heinrich RÖDER, Joanna Röder, Laura Maguire, Robert W. Georgantas, III, Thomas Campbell, Lelia Net
  • Publication number: 20220189638
    Abstract: A method for predicting an unfavorable outcome for a patient admitted to a hospital, e.g., with a COVID-19 infection is described. Attributes from an electronic health record for the patient are obtained including at least findings obtained at admission, basic patient characteristics, and laboratory data. The attributes are supplied to a classifier implemented in a programmed computer which is trained to predict a risk of the unfavorable outcome. The classifier is arranged as a hierarchical combination of (a) an initial binary classifier stratifying the patient into either a high risk group or a low risk group, and (b) child classifiers further classifying the patient in a lowest risk group or a highest risk group depending how the initial binary classifier stratified the patient as either a member of the high risk or low risk group.
    Type: Application
    Filed: June 10, 2021
    Publication date: June 16, 2022
    Applicant: BIODESIX, INC.
    Inventors: Thomas CAMPBELL, Robert W. GEORGANTAS, III, Heinrich RÖDER, Joanna RÖDER, Laura MAGUIRE